FOXO3 and cancer: This resembles the heterogeneity of NB tumors in vivo and suggests that cultured patient-derived cancer cells reflect the stage-dependent differences in PKB-activity and FOXO3-phosphorylation observed in tissue biopsies (Figure 1).